Hemant Surgical Industries

Hemant Surgical Industries

318.75
-318.75
(-100.00%)
Market Cap
332.80 Cr
EPS
7.70
PE Ratio
42.05
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
367.10
52 Week Low
88.15
PB Ratio
5.27
Debt to Equity
0.49
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%

Company News

View All News
Caret
neutral
Hemant Surgical Industries Limited has allotted 600,000 warrants convertible into equity shares to its promoters and promoter group on September 16, 2025. The warrants were distributed equally among three promoters: Hanskumar Shamji Shah, Hemant Praful Shah, and Kaushik Hanskumar Shah, with each receiving 200,000 warrants. Each warrant can be converted into one fully paid-up equity share with a face value of Rs. 10 within 18 months from the allotment date. Following this allotment, the promoter group's total holding increased to 86,80,000 shares, representing 64.67% of the total voting capital. The company's equity share capital after the acquisition stands at Rs. 13,03,84,000 comprising 1,30,38,400 equity shares, while the total diluted share capital reaches Rs. 15,13,76,000 with 1,51,37,600 equity shares.
positive
Hemant Surgical Industries Limited has allotted 20,99,200 warrants on a preferential basis at Rs. 197 per warrant, raising Rs. 10.34 crores as 25% upfront payment. The allotment includes both promoter and non-promoter entities, with three Singularity funds receiving 15,99,200 warrants and three promoter individuals (Hemant Praful Shah, Hanskumar Shamji Shah, and Kaushik Hanskumar Shah) receiving 2,00,000 warrants each. Each warrant is convertible into one equity share of Rs. 10 face value at a premium of Rs. 187 within 18 months from the allotment date. The remaining 75% consideration of Rs. 147.75 per warrant will be payable upon conversion. Post-conversion, the promoter shareholding will range from 15.42% to 29.72% on a fully diluted basis, while the Singularity funds will hold between 1.60% to 7.18%.
positive
Hemant Surgical Industries has received a purchase order worth Rs. 82.89 crore from the Government of India for the supply of X-ray machines. This government contract represents a significant business opportunity for the medical equipment manufacturer.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,951.00
#1 19,768.60
55.30
#1 1,759.00
22.62
#1 339
25.81
44.32
327.75
1,801.40
77.90
242.40
24.12
25
-50.60
42.58
309.00
1,644.10
59.59
408.40
32.64
30
-55.00
29.32
605.00
1,005.60
61.67
249.37
40.00
17
-20.59
47.36
596.00
961.30
47.95
186.60
40.62
20
-
53.31
547.00
656.60
34.75
67.10
13.15
18
18.92
41.96
274.95
523.50
#1 32.50
136.30
#1 107.77
16
-
60.73
318.75
#8 332.80
#4 42.05
#8 111.80
#10 -1.43
#8 8
#4 -0.10
48.51
287.00
301.70
37.71
89.85
0.60
7
#1 752.54
55.44
230.78
230.80
-
122.10
19.24
1
-52.94
36.02
Forecast
Actual
Growth Rate
Revenue Growth
-1.43 %
Net Income Growth
28.95 %
Cash Flow Change
-93.79 %
ROE
-45.38 %
ROCE
-47.22 %
EBITDA Margin (Avg.)
16.96 %

Yearly Financial Results

Annual Financials
2025
TTM
Revenue
112
0
Expenses
98
0
EBITDA
14
0
Operating Profit %
8 %
0 %
Depreciation
1
0
Interest
2
0
Profit Before Tax
11
0
Tax
2
0
Net Profit
8
0
EPS in ₹
7.70
0.00

Balance Sheet

Balance Sheet
2025
Total Assets
148
Fixed Assets
40
Current Assets
89
Capital Work in Progress
12
Investments
0
Other Assets
97
Total Liabilities
148
Current Liabilities
61
Non Current Liabilities
24
Total Equity
63
Reserve & Surplus
53
Share Capital
10

Cash Flow

Cash Flow
2025
Net Cash Flow
-4
Investing Activities
-30
Operating Activities
9
Financing Activities
18

Share Holding

% Holding
Jun 2023
Sept 2023
Mar 2024
Sept 2024
Mar 2025
Jun 2025
Promoter
73.56 %
73.56 %
73.56 %
73.56 %
73.56 %
58.90 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.39 %
0.15 %
DIIs
0.49 %
0.00 %
1.97 %
1.13 %
1.11 %
10.81 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
11.00 %
17.47 %
20.64 %
20.24 %
20.87 %
23.17 %
Others
14.94 %
8.97 %
3.82 %
5.07 %
4.06 %
6.97 %
No of Share Holders
830
722
1,229
1,248
1,229
748

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 160.50 154.50
13 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2024 147.00 146.55
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 106.00 105.00
30 Aug 2025 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
30 Aug 2025 234.00 292.00
23 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Sept 2025 290.70 352.65

Announcements

Closure of Trading Window5 days ago
Shareholder Meeting / Postal Ballot-Scrutinizers Report9 days ago
Shareholder Meeting / Postal Ballot-Outcome of AGM9 days ago
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 201110 days ago
Announcement under Regulation 30 (LODR)-AllotmentSep 18, 2025
Announcement under Regulation 30 (LODR)-AllotmentSep 16, 2025
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderSep 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportSep 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMAug 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 30, 2025
Dispatch Of Letter To ShareholdersAug 29, 2025
Reg. 34 (1) Annual Report.Aug 29, 2025
Notice Of The 36Th Annual General Meeting (AGM) Of The Company To Be Held On September 23 2025Aug 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 29, 2025
Intimation For 36Th Annual General Meeting Scheduled To Be Held On Tuesday September 23 2025.Aug 28, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateAug 28, 2025
Intimation Of Appointment Of Secretarial Auditor Cost Auditor And Internal Auditor.Aug 28, 2025
Board Meeting Outcome for Held On Thursday August 28 2025Aug 28, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 11, 2025
Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository ParticipantsAug 08, 2025
Notice Of An Extra-Ordinary General Meeting Of The CompanyAug 08, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 07, 2025
Board Meeting Outcome for Held On Wednesday August 06 2025Aug 06, 2025
Closure of Trading WindowAug 01, 2025
Board Meeting Intimation for To Consider Proposal For Fund RaisingAug 01, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 09, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Statement Of Deviation & VariationMay 28, 2025
Audited Results For Half And Financial Year Ended March 31 2025May 28, 2025
Board Meeting Outcome for Held On Wednesday May 28 2025May 28, 2025
Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For Half And Financial Year Ended On March 31 2025.May 16, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 13, 2025
Intimation Under Regulation 30 Of SEBI (LODR) Regulations 2015Feb 24, 2025
Compliances-Certificate Under Reg. 74(5) Of SEBI (Depositories And Participants) Regulations 2018 For The Quarter Ended December 31 2024.Jan 13, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateJan 02, 2025
Intimation For Change Of Corporate Identification Number (CIN) And Company Status Of Hemant Surgical Industries Limited ('The Company') On MCA Website.Dec 11, 2024
Statement Of Deviation For The Period Ended On September 30, 2024Nov 13, 2024
Un-Audited Financial Results Of The Company For The Half Year Ended On September 30, 2024.Nov 13, 2024
Board Meeting Outcome for The Meeting Held On Wednesday, November 13, 2024Nov 13, 2024
Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company Will Be Held On Wednesday, November 13, 2024.Nov 05, 2024
Additional Details Required For Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations, 2015Oct 10, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 09, 2024
Intimation Of The Fire IncidentOct 09, 2024
Closure of Trading WindowSep 30, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportSep 26, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 25, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 03, 2024

Technical Indicators

RSI(14)
Neutral
52.26
ATR(14)
Volatile
7.07
STOCH(9,6)
Oversold
3.88
STOCH RSI(14)
Oversold
2.63
MACD(12,26)
Bearish
-8.21
ADX(14)
Very Strong Trend
54.02
UO(9)
Bearish
35.47
ROC(12)
Downtrend And Accelerating
-7.88
WillR(14)
Neutral
-79.52